{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:41:05Z","timestamp":1781649665652,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"16-17","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.clinbiochem.2012.07.085","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T00:37:55Z","timestamp":1342744675000},"page":"1525-1530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Novel alpha-galactosidase A mutation in a female with recurrent strokes"],"prefix":"10.1016","volume":"45","author":[{"given":"Antonino","family":"Tuttolomondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Duro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Serio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Albeggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Iemolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafina","family":"Sciarrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0005","series-title":"The metabolic and molecular basis of inherited disease","first-page":"3733","article-title":"a-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0010","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/nar\/17.8.3301","article-title":"Nucleotide sequence of the human a-galactosidase A gene","volume":"17","author":"Kornreich","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0015","first-page":"3903","article-title":"Structural organization of the human \u03b1-galactosidase A gene: further evidence for the absence of a 3\u2032 untraslated region","volume":"85","author":"Bishop","year":"1988","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.085_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1096-7192(02)00012-4","article-title":"Fabry disease: 45 novel mutations in the \u03b1-galactosidase A gene causing the classical phenotype","volume":"76","author":"Shabbeer","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/190372a0","article-title":"Gene action in the X-chromosome of the mouse (Mus musculus L)","volume":"190","author":"Lyon","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.md.0000178976.62537.6b","article-title":"The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women","volume":"84","author":"Gupta","year":"2005","journal-title":"Medicine"},{"issue":"Suppl. 447","key":"10.1016\/j.clinbiochem.2012.07.085_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1651-2227.2005.tb02106.x","article-title":"Natural history of the cerebrovascular complications of Fabry disease","volume":"94","author":"Mehta","year":"2005","journal-title":"Acta Paediatr"},{"issue":"9499","key":"10.1016\/j.clinbiochem.2012.07.085_bb0150","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"9","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1399-0004.2006.00594.x","article-title":"A successful approach for the detection of Fabry patients in Argentina","volume":"69","author":"Rozenfeld","year":"2006","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.085_bb0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnosis in dried blood spots on filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ab.2004.10.007","article-title":"Enhanced filter paper enzyme assay for high-throughput population screening for Fabry disease","volume":"337","author":"Poeppl","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0065","first-page":"1S76","article-title":"Laboratory diagnosis of Fabry disease: historical perspectives and recent breakthroughs","volume":"36","author":"Caudron","year":"2007","journal-title":"Presse Med."},{"issue":"9","key":"10.1016\/j.clinbiochem.2012.07.085_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry Womenare not just carrier, but have a significant burden of disease and impaired quality of life","volume":"1","author":"Wang","year":"2007","journal-title":"Genetic in medicine"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0888-7543(92)90288-4","article-title":"Invariant exon skipping in the human cc-galactosidase A premRNA: a g\u20331 to t substitution in a 5\u2032-splice site causing Fabry disease","volume":"12","author":"Sakuraba","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0080","first-page":"784","article-title":"Identification of point mutations in the a-galactosidase A gene in classical and atypical hemizygotes with Fabry disease","volume":"47","author":"Sakuraba","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0014-5793(90)80046-L","article-title":"A case of Fabry's disease in a patient with no a-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser","volume":"259","author":"Koide","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1651-2227.2008.00642.x","article-title":"Fabry disease: Beyond men","volume":"97","author":"Metha","year":"2008","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.07.085_bb0095","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry's disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0105","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease","volume":"251","author":"Hilz","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0110","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1552-6569.2001.tb00051.x","article-title":"Selective arterial distribution of cerebral hyperperfusion in Fabry disease","volume":"11","author":"Moore","year":"2001","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson\u2013Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.clinbiochem.2012.07.085_bb0130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.085_bb0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/STROKEAHA.109.558320","article-title":"Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke","volume":"41","author":"Wozniak","year":"2010","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.07.085_bb0140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/STROKEAHA.109.570499","article-title":"Ferro JM; PORTuguese Young STROKE InvestigatorsMutations of the GLA gene in young patients with stroke: the PORTYSTROKE study\u2013screening genetic conditions in Portuguese young stroke patients","volume":"41","author":"Baptista","year":"2010","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.07.085_bb0145","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/STROKEAHA.110.579409","article-title":"BeFaS Investigators. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease","volume":"41","author":"Brouns","year":"2010","journal-title":"Stroke"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012004286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012004286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:40:05Z","timestamp":1757864405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012004286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":29,"journal-issue":{"issue":"16-17","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0009912012004286"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.07.085","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel alpha-galactosidase A mutation in a female with recurrent strokes","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.07.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}